A detailed history of Walleye Capital LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 8,000 shares of FLGT stock, worth $161,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,000
Previous 22,100 63.8%
Holding current value
$161,040
Previous $433,000 60.05%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.09 - $22.57 $66,967 - $79,175
3,508 Added 18463.16%
3,527 $69,000
Q1 2024

May 15, 2024

SELL
$21.55 - $29.29 $204,746 - $278,284
-9,501 Reduced 99.8%
19 $0
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $225,052 - $288,170
9,520 New
9,520 $275,000
Q1 2023

May 15, 2023

BUY
$29.39 - $36.27 $48,816 - $60,244
1,661 Added 7.06%
25,181 $786,000
Q4 2022

Feb 14, 2023

BUY
$29.23 - $40.28 $332,900 - $458,748
11,389 Added 93.88%
23,520 $700,000
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $460,007 - $773,229
12,131 New
12,131 $462,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.